We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Kit Provides Quantitative Determination of Haptoglobin in Human Serum

By LabMedica International staff writers
Posted on 27 Jan 2011
A new liquid stable haptoglobin kit provides a highly sensitive and specific method for the quantitative determination of haptoglobin in human serum.

The method is fully automated and suitable for use on the RX series of bench top clinical analyzers including the RX daytona and RX imola. More...
Liquid, ready-to-use quality controls and calibrators are also available. Liquid specific protein controls are stable for 30 days at 2 °C to 8 °C and are 100% human in origin. Three clinically significant levels are available with assayed target values and ranges for 27 different analytes including haptoglobin.

A product of Randox (Crumlin, UK) the haptoglobin assay is based on an immunoturbidimetric method where haptoglobin in the sample is diluted and reacted with specific antiserum, yielding insoluble aggregates that can be measured turbidimetrically at 340 nm.

A wide measuring range of 0.13 g/L to 3.68 g/L ensures that the assay is capable of accurately measuring above and below the patient normal range while an extended onboard stability of 28 days minimizes reagent waste.

The assay is precise, traceable to certified reference material, and has limited interference from bilirubin, hemoglobin, and triglycerides. Prozone effects are not demonstrated up to at least 7.64 g/L and the assay shows excellent correlation to standard methods.

In addition to quality controls, Randox also offers a specific protein EQA program providing customers with a complete quality management solution. The bi-weekly RIQAS program comprises 26 proteins and allows assessment of analytical performance in comparison to other laboratories using the same method/instrument.

Haptoglobin is an acute phase protein made primarily in the liver. Its main function is to bind free hemoglobin and remove it from circulation preventing damage to the kidneys and loss of iron following hemolysis.

Measurements of haptoglobin are mainly used to diagnose hemolytic anemia and to distinguish it from other types of anemia. In cases of hemolytic anemia, haptoglobin levels in the blood decrease significantly. However, low levels may also indicate red blood cell destruction due to sickle cell anemia or thalassemia.

As an acute phase reactant, haptoglobin levels in the blood are significantly increased in response to infection, inflammation, burns, surgery, and trauma, but haptoglobin is not generally used to diagnose or monitor these conditions.

Related Links:

Randox



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.